PLUS1
1.59
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Regular Market
| Volume | 321,170 |
|
|||||
| News | - | ||||||
| Day High | 1.605 | Low High |
|||||
| Day Low | 1.52 | ||||||
Best deals to access real time data! |
|
USA Big Cap Pro
Monthly Subscription
for only
|
|
USA Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime USA (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Adverum Biotechnologies Inc | ADVM | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
 |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 1.59 | 06:35:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.57 | 1.52 | 1.605 | 1.59 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,559 | 321,170 | US$ 1.56 | US$ 501,819 | - | 1.465 - 14.60 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 06:36:40 | 100 | US$ 1.59 | USD |
Period:
Draw Mode:
Adverum Biotechnologies Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 156.06M | 98.15M | 92.43M | US$ - | US$ - | -1.37 | -1.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | 395.23k | 5.90% |
Adverum Biotechnologies News
| Date | Time | Source | News Article |
|---|---|---|---|
| 07/1/2022 | 08:05 | GlobeNewswire Inc. | Adverum Biotechnologies Appoints Star Seyedkazemi, Pharm.D... |
| 05/1/2022 | 00:00 | GlobeNewswire Inc. | Adverum Biotechnologies Granted Orphan Drug Designation by.. |
| 04/1/2022 | 03:57 | Seeking Alpha | Adverum granted FDA’s Orphan Drug Designation for treatment.. |
| 22/12/2021 | 00:02 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 22/12/2021 | 00:00 | GlobeNewswire Inc. | Adverum Biotechnologies Provides ADVM-022 Development Update.. |
| 11/12/2021 | 09:26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 07/12/2021 | 01:03 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 07/12/2021 | 01:00 | GlobeNewswire Inc. | Adverum Biotechnologies Appoints Rupert D’Souza, Ph.D.,.. |
| 18/11/2021 | 08:38 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 05/11/2021 | 08:32 | Seeking Alpha | Adverum Biotechnologies EPS misses by $0.01 |
| 05/11/2021 | 07:20 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 05/11/2021 | 07:14 | Edgar (US Regulatory) | Current Report Filing (8-k) |
Historical ADVM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.625 | 1.64 | 1.465 | 1.56 | 1,005,161 | -0.035 | -2.15% |
| 1 Month | 1.80 | 2.04 | 1.465 | 1.75 | 1,610,155 | -0.21 | -11.67% |
| 3 Months | 2.26 | 2.37 | 1.465 | 1.85 | 1,291,799 | -0.67 | -29.65% |
| 6 Months | 2.33 | 2.59 | 1.465 | 2.14 | 1,809,171 | -0.74 | -31.76% |
| 1 Year | 13.31 | 14.60 | 1.465 | 3.73 | 1,932,468 | -11.72 | -88.05% |
| 3 Years | 3.11 | 26.98 | 1.465 | 8.13 | 1,421,452 | -1.52 | -48.87% |
| 5 Years | 2.95 | 26.98 | 1.465 | 7.50 | 1,081,262 | -1.36 | -46.1% |
